Yahoo News: Cancer

Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts

Mon, 01/12/2015 - 12:40
ZURICH/LOS ANGELES (Reuters) - Roche Holding will acquire a majority stake in molecular and genomic analysis business Foundation Medicine, it said on Monday, signaling its determination to expand in cancer immunotherapy by paying a hefty mark-up on the U.S. company's current price. The deal will help the world's largest maker of cancer drugs push ahead in developing treatments that help the body ...

Merck speeds up drug-submission plans for Hep C, lung cancer: WSJ

Mon, 01/12/2015 - 06:51
(Reuters) - Merck & Co has put on fast track its plans to submit new drugs for hepatitis C and lung cancer for regulatory approval, in an attempt to close the gap with competitors in two lucrative segments, the Wall Street Journal reported. The drugmaker will file an application midyear for U.S. regulatory approval to expand the use of its new cancer immunotherapy Keytruda to include the ...

Bristol-Myers says panel finds Opdivo lung cancer study meets endpoint

Mon, 01/12/2015 - 03:36
(Reuters) - Bristol-Myers Squibb Co said the independent data monitoring committee concluded that a late stage study evaluating Opdivo versus docetaxel in previously treated patients with advanced, squamous cell non-small cell lung cancer met its endpoint. The company said the data demonstrates superior overall survival in patients receiving Opdivo compared to the control arm, indicating a ...

Conn. Supreme Court Rules 17-Year-Old Cancer Patient Must Have Chemo

Fri, 01/09/2015 - 04:13
The top court in Connecticut ruled today that a 17-year-old girl can be forced to undergo chemotherapy after she refused treatment for her cancer.The case went to the Connecticut Supreme court to determine whether the teen, identified in court papers as Cassandra, has "the fundamental right to have a say about what goes on with your [her] body," attorney Michael Taylor, who represents the teen's ...

Docs suggest HPV screening first for cervical cancer

Thu, 01/08/2015 - 22:14
By Andrew M. Seaman (Reuters Health) - Two medical organizations have recommended testing for the human papillomavirus (HPV) to screen women for cervical cancer before using a Papanicolaou – or Pap – smear for screening. The new guidance is not universally accepted by all major medical organizations. However, the document does give some direction to doctors who may use the HPV test for screening ...

Analysts: Pfizer's new type of cancer drug may get OK early

Thu, 01/08/2015 - 20:33
The first in a new class of cancer medicines, Pfizer's Ibrance, appears poised for approval to treat advanced breast cancer within a few months and could quickly become a blockbuster, some analysts believe. ...

CytRx cancer drug shows promise in mid-stage study

Thu, 01/08/2015 - 14:35
(Reuters) - CytRx Corp said its cancer drug was effective against a type of skin cancer in HIV+ patients, sending its shares up 13 percent before the bell. Interim data from an ongoing mid-stage study showed that the drug, aldoxorubicin, stopped tumor growth in HIV+ patients suffering from Kaposi's Sarcoma, the company said on Thursday. The U.S. Food and Drug Administration placed a hold on ...

GW Pharma's cannabis drug fails in cancer pain study, shares fall

Thu, 01/08/2015 - 14:10
By Ben Hirschler LONDON (Reuters) - An experimental cannabis drug failed to alleviate pain in cancer patients as hoped in a clinical study, sending shares in its British maker GW Pharmaceuticals as much as 21 percent lower on Thursday. GW, which is developing the drug Sativex for pain in collaboration with Japan's Otsuka, said the first of three late-stage trials found no statistically ...

Top Connecticut court to hear arguments on teen's cancer care

Thu, 01/08/2015 - 12:03
By Richard Weizel HARTFORD, Conn. (Reuters) - A Connecticut teenager diagnosed with cancer, who has been forced for the past month to receive state-ordered chemotherapy over her family's objections, will ask the state's top court on Thursday to order a stop to the treatments. The teen was diagnosed with what doctors say is an aggressive, but curable cancer in September, days before her 17th ...

Halozyme CEO sees blockbuster potential in its cancer drug

Wed, 01/07/2015 - 23:26
By Bill Berkrot NEW YORK (Reuters) - Halozyme Therapeutics Inc believes it has a multibillion-dollar cancer drug on its hands. The drug, PEGPH20, being tested against pancreatic cancer, has the potential to help treat several other types of solid tumor cancers, its chief executive said in an interview. Halozyme discussed interim data from a Phase II study of PEGPH20 with analysts and investors ...

Cytrx cancer drug shows promise in mid-stage study

Tue, 01/06/2015 - 11:32
(Reuters) - Cytrx Corp said interim data showed its experimental cancer drug was effective in a mid-stage study to treat patients with a deadly form of brain cancer. The drug, aldoxorubicin, prevented the disease from progressing and shrank tumors, the company said. The U.S. Food and Drug Administration had placed a hold on enrolling new patients in clinical trials of aldoxorubicin in November ...

Radiation plus hormone therapy saves lives in prostate cancer

Mon, 01/05/2015 - 23:19
Older men with prostate cancer may live longer if they receive a combination of radiation and hormone therapy, but many men do not get the right treatment, US researchers said Monday. The dual therapy saved nearly 50 percent more lives among men aged 76 to 85 with locally advanced prostate cancer, compared to those who received hormone therapy alone, said the findings in the Journal of Clinical ...

Amgen, Kite Pharma team up on immune-based cancer drugs

Mon, 01/05/2015 - 19:58
Amgen Inc. and Kite Pharma Inc. will team up to develop advanced cancer treatments using key components of the immune system called T cells. It's the latest partnership in the recent wave of pharmaceutical ...

For Some, Less Radiation for Breast Cancer Makes Sense (Op-Ed)

Mon, 01/05/2015 - 19:18
Dr. Lucille Lee is an attending physician in the Department of Radiation Medicine at North Shore-LIJ's Cancer Institute and is a board-certified radiation oncologist specializing in the treatment of breast and prostate cancer. She specializes in multiple techniques including partial breast irradiation and breast hypofractionation. New research published in the Journal of the American Medical ...

Amgen, Kite Pharma ink deal to develop cancer immunotherapies

Mon, 01/05/2015 - 14:58
(Reuters) - Amgen Inc and Kite Pharma Inc said they entered into a deal to develop and market cancer immunotherapies using Amgen's cancer targets and Kite's technology platform. Amgen will pay Kite Pharma $60 million upfront and fund research costs through the filing of a new drug application. After that each company will conduct and fund trials for their therapeutic candidates, they said in a ...

Utah woman dies after inspirational cancer fight

Sun, 01/04/2015 - 23:47
BEAR RIVER, Utah (AP) — Kathy Taylor, who inspired singer Sarah McLachlan and others, has died in Utah after a fight against cancer while pregnant with her sixth child. She was 34.

ESPN sportscaster Scott dies after cancer battle

Sun, 01/04/2015 - 20:16
Stuart Scott, an ESPN sportscaster whose use of pop culture references and wordplay earned him a loyal following among US fans and the athletes he covered, died Sunday at the age of 49. ESPN, the network he joined in 1993, said Scott died of cancer, having battled recurrent bouts of the disease since he was first diagnosed in November of 2007. Scott anchored ESPN's flagship SportsCenter shows ...

Longtime ESPN sportscaster Stuart Scott dies at age 49

Sun, 01/04/2015 - 19:48
(Reuters) - Longtime ESPN sportscaster Stuart Scott, known for catchphases that became part of the lexicon of sports, has died of cancer, the network said on Sunday. He was 49. After first being diagnosed with cancer in November 2007 following an emergency appendectomy, Scott fought through three bouts of cancer, the network said. “ESPN and everyone in the sports world have lost a true friend ...

ESPN Anchor Stuart Scott Dies at 49

Sun, 01/04/2015 - 05:00
The veteran sportscaster died of cancer less than six months after he accepted the Jimmy V Perseverance Award in an emotional moment at the ESPYs

Longtime ESPN Sportscaster Stuart Scott Dies at 49

Sun, 01/04/2015 - 05:00
Scott had fought cancer since a diagnosis in late 2007, the network said, but remained dedicated to his craft even as he underwent chemotherapy, radiation and surgery.